Evidence map›Paper›PMID 28874101›Full record

ArticleStem cells and development2017

The Role of Cellular Proliferation in Adipogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells.

Maribel P Marquez, Frances Alencastro, Alma Madrigal, Jossue Loya Jimenez, Giselle Blanco, Alex Gureghian, Laura Keagy, Cecilia Lee, Robert Liu, Lun Tan and 3 more

Open access · greenAbstract read
In one paragraph

Article in Stem cells and development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. STIM2β is a CaThe FEBS journal · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Adipocyte · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Maribel P Marquez1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Frances Alencastro1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Alma Madrigal1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Jossue Loya Jimenez1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Giselle Blanco1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Alex Gureghian1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Laura Keagy1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Cecilia Lee1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Robert Liu1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Lun Tan1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Kristen Deignan1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
Brian Armstrong2 Imaging Core , City of Hope, Duarte, California.
Yuanxiang Zhao1 Biological Sciences Department, California State Polytechnic University at Pomona , Pomona, California.
California State Polytechnic University · USCity Of Hope National Medical Center · US

Funding

Molecular and Cellular Profiling of Human AdipogensisSC3GM116720 · NIGMS · CALIFORNIA STATE POLY U POMONA · PI ZHAO, YUANXIANG · 2016 to 2019
$435k
Adipogenic Toxicity Study of Obesogenic DrugsSC3GM094078 · NIGMS · CALIFORNIA STATE POLY U POMONA · PI ZHAO, YUANXIANG · 2010 to 2013
$416k
NIGMS NIH HHS SC3 GM094078NIGMS NIH HHS SC3 GM116720
6 · The paper itself

Abstract

Mitotic clonal expansion has been suggested as a prerequisite for adipogenesis in murine preadipocytes, but the precise role of cell proliferation during human adipogenesis is unclear. Using adipose tissue-derived human mesenchymal stem cells as an in vitro cell model for adipogenic study, a group of cell cycle regulators, including Cdk1 and CCND1, were found to be downregulated as early as 24 h after adipogenic initiation and consistently, cell proliferation activity was restricted to the first 48 h of adipogenic induction. Cell proliferation was either further inhibited using siRNAs targeting cell cycle genes or enhanced by supplementing exogenous growth factor, basic fibroblast growth factor (bFGF), at specific time intervals during adipogenesis. Expression knockdown of Cdk1 at the initiation of adipogenic induction resulted in significantly increased adipocytes, even though total number of cells was significantly reduced compared to siControl-treated cells. bFGF stimulated proliferation throughout adipogenic differentiation, but exerted differential effect on adipogenic outcome at different phases, promoting adipogenesis during mitotic phase (first 48 h), but significantly inhibiting adipogenesis during adipogenic commitment phase (days 3-6). Our results demonstrate that cellular proliferation is counteractive to adipogenic commitment in human adipogenesis. However, cellular proliferation stimulation can be beneficial for adipogenesis during the mitotic phase by increasing the population of cells capable of committing to adipocytes before adipogenic commitment.

Indexed as

AdipogenesisCell ProliferationAdipose TissueCDC2 Protein KinaseCells, CulturedCyclin D1Fibroblast Growth Factor 2HumansMesenchymal Stem CellsCCND1 protein, humanCDC2 Protein KinaseCDK1 protein, humanCyclin D1Fibroblast Growth Factor 2adipogenesisbasic fibroblast growth factor (bFGF)cell cycle regulatorcell proliferationhuman mesenchymal stem cells (hMSCs)

Identifiers

PMID28874101
PMCPMC5662072
OpenAlexW2766894908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.